Dyspepsia history and symptoms

Jump to navigation Jump to search

Dyspepsia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dyspepsia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dyspepsia history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dyspepsia history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dyspepsia history and symptoms

CDC on Dyspepsia history and symptoms

Dyspepsia history and symptoms in the news

Blogs on Dyspepsia history and symptoms

Directions to Hospitals Treating Dyspepsia

Risk calculators and risk factors for Dyspepsia history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahad Hasan, M.D.[2] Ajay Gade MD[3]]

Overview

Dyspepsia is a symptom complex, not a diagnosis, arising from the gastroduodenal region. Its four cardinal symptoms are bothersome postprandial fullness, early satiation, epigastric pain, and epigastric burning. Nausea, upper-abdominal bloating, and belching are supportive but not defining features.[1][2] Heartburn and regurgitation are not dyspeptic symptoms and indicate gastroesophageal reflux disease (GERD), although they frequently coexist with and do not exclude functional dyspepsia (FD).[1][2] History and examination cannot reliably distinguish functional from organic dyspepsia, and no accurate biomarker exists. The history is therefore used to identify alarm features, culprit medications, and Helicobacter pylori risk rather than to establish etiology.[1][3]

History and Symptoms

History

The history in dyspepsia has three purposes: (1) confirm that symptoms are epigastric-predominant rather than heartburn-predominant; (2) screen for alarm features and age/risk factors that direct endoscopy; and (3) identify culprit medications and H. pylori risk. Symptom pattern alone discriminates poorly between functional and organic causes and should not be used to make an etiologic diagnosis.[1][4]

Predominant symptom and relation to meals

  • Identify the predominant symptom to support Rome IV subtyping: postprandial fullness/early satiation favors postprandial distress syndrome (PDS); epigastric pain/burning favors epigastric pain syndrome (EPS).[2]
  • Establish the timing relative to meals. Meal-related symptoms characteristically emerge or worsen within 2 hours of eating; symptoms that appear or worsen later than 2 hours may have a different pathophysiologic basis.[5]
  • Localize the pain. EPS pain should be clearly localized to the central upper abdomen, above the umbilicus. Pain relieved by defecation or passage of flatus is not dyspepsia and points to a bowel disorder.[5]
  • A meal-relieved, nocturnal, or "hunger" pain pattern may raise suspicion for peptic ulcer disease (particularly duodenal ulcer), but this pattern has limited predictive value for an underlying ulcer.[3][6]

Alarm features

Screen every patient for the following alarm ("red flag") features:[7]

Age ≥60 years is the dominant driver of endoscopy. Per the 2017 ACG/CAG guideline, an isolated alarm feature in a patient <60 years does not by itself mandate endoscopy, because the absolute malignancy risk in this group remains well below 1%. Endoscopy is individualized when a feature is prominent (e.g., weight loss >20 lb, rapidly progressive dysphagia) or when several features coexist.[7][8] See Dyspepsia other diagnostic studies for endoscopy indications.

Weight loss, although classified as an alarm feature, is common in FD itself and was profound (≥10 kg) in approximately 15% of a well-characterized FD cohort; it should be interpreted in context.[4]

Medication history

Social, family, and psychosocial history

  • Smoking: heavy smoking is a strong risk factor for FD and should be documented.[9]
  • Alcohol use: document quantity and pattern.
  • H. pylori risk: infection is more common with lower socioeconomic status, birth or childhood in a high-incidence region, and household exposure. These factors support H. pylori testing and lower the threshold for endoscopy.[10][11]
  • Psychological comorbidity: approximately one-third of patients with FD have anxiety, depression, or both. The relationship is bidirectional: anxiety may predispose to FD, and FD may induce later anxiety and depression.[9]
  • Post-infectious onset: new dyspepsia after an episode of acute gastroenteritis supports post-infectious FD.[9]

Symptoms

Dyspeptic symptoms are typically chronic and relapsing–remitting.

Category Symptoms Clinical significance
Cardinal (defining) Epigastric pain; epigastric burning; postprandial fullness; early satiation At least one is required to define dyspepsia[2]
Supportive Upper-abdominal bloating; nausea (particularly postprandial); belching; loss of appetite Common and supportive, but not defining[1][2]
Features pointing to another diagnosis Persistent or predominant vomiting Not typical of dyspepsia; consider gastroparesis, chronic nausea and vomiting syndrome, or gastric outlet obstruction[5]
Heartburn, regurgitation Coexisting GERD rather than dyspepsia[1]
Pain relieved by defecation or flatus Bowel disorder rather than dyspepsia[5]

Rome IV symptom framework and subtypes

Functional dyspepsia is diagnosed clinically when one or more cardinal symptoms have been present for the last 3 months, with symptom onset ≥6 months before diagnosis, and no structural disease on evaluation explains them.[2]

Subtype Defining bothersome symptoms Minimum frequency
Postprandial distress syndrome (PDS) Postprandial fullness and/or early satiation ≥3 days/week
Epigastric pain syndrome (EPS) Epigastric pain and/or epigastric burning (fasting or postprandial) ≥1 day/week
PDS–EPS overlap Features of both subtypes As for each subtype

Classifying any postprandial symptom as PDS under Rome IV reduced PDS–EPS overlap to <20%.[1] Dyspepsia commonly overlaps with GERD (30–50%) and with irritable bowel syndrome (approximately one-third to one-half of patients). Overlap is associated with more severe symptoms and greater psychological comorbidity.[1][9]

Clinically Actionable Recommendations

  • Confirm that symptoms are epigastric-predominant; evaluate heartburn-predominant patients for GERD.[1]
  • Subtype by predominant symptom and meal relationship (PDS vs EPS); meal-related symptoms emerge within 2 hours of eating.[2][5]
  • Screen every patient for alarm features, age, and gastric-cancer risk factors. Refer patients ≥60 years for endoscopy; an isolated alarm feature <60 years does not by itself mandate endoscopy; lower the threshold in high-risk populations.[7][10]
  • Perform a structured medication review and stop unnecessary NSAIDs/aspirin before further testing.[5]
  • Determine H. pylori status in patients with dyspeptic symptoms; use test-and-treat in patients <60 years without alarm features (see Dyspepsia laboratory findings).[7][10]
  • Document psychological comorbidity and post-infectious onset, both of which inform management.[9]

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Ford, et al. Lancet. 2020.
  2. ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Stanghellini, et al. Rome IV gastroduodenal disorders. Gastroenterology. 2016.
  3. ↑ 3.0 3.1 Vakil. JAMA. 2024.
  4. ↑ 4.0 4.1 Sayuk, Gyawali. Drugs. 2020.
  5. ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 Törnblom, et al. Gastroenterology. 2026.
  6. ↑ Lanas, Chan. Lancet. 2017.
  7. ↑ 7.0 7.1 7.2 7.3 Moayyedi, et al. ACG and CAG clinical guideline: management of dyspepsia. 2017.
  8. ↑ Feld, Cifu. JAMA. 2018.
  9. ↑ 9.0 9.1 9.2 9.3 9.4 Pasricha, Talley. N Engl J Med. 2026.
  10. ↑ 10.0 10.1 10.2 Chey, et al. ACG clinical guideline: Helicobacter pylori infection. 2024.
  11. ↑ Crowe. N Engl J Med. 2019.

Template:WH Template:WS